88IV - PR Newswire Asia's news - Health Care/Hospital


Ractigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms Funding led by Guozhong Capital will accelerate Phase 2 development for saRNA candidate RAG-01 and CNS asset RAG-17, advance systemic saRNA program RAG-18 toward IND, and expand extrahepatic RNA delivery ... 2026-07-29T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma FDA Fast Track Designation (FTD) aims to accelerate the review process of high-value assets, and ISM6331 marks Insilico's first FTD, recognizing the clinical potential in advanced mesothelioma. ISM6331 ... 2026-07-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Fosun International Issues Positive Profit Alert: Profit Attributable to Owners of the Parent for 1H2026 Expected to be Approx. RMB 1.5 Billion to RMB1.8 Billion HONG KONG , July 29, 2026 /PRNewswire/ -- On 29 th July, Fosun International (00656.HK) issued a positive profit alert. Its profit attributable to owners of the parent for the first half of 2026 is ... 2026-07-29T Banking/Financial Service Health Care/Hospital Insurance
Ping An Ranks 48th on 2026 Fortune Global 500 List, Marking 17th Consecutive Year on List HONG KONG and SHANGHAI , July 29, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group"; HKEX: 2318; SSE: 601318) ... 2026-07-29T Banking/Financial Service Health Care/Hospital Insurance
Wellness Culture Gains Momentum Across Asia Pacific as 4 in 5 Consumers Prioritize Holistic Health - Herbalife Survey HONG KONG , July 29, 2026 /PRNewswire/ -- Herbalife, a premier health and wellness company, community and platform, released findings from its latest survey, revealing a clear rise in a wellness culture ... 2026-07-29T Health Care/Hospital
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer ELAHERE is the first and only antibody-drug conjugate (ADC) therapy approved specifically for patients with folate receptor alpha (FRα) positive, platinum-resistant high grade serous epithelial ovarian ... 2026-07-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Australian medtech Navi raises $A6.8 million to commercialise breakthrough paediatric technology in the US MELBOURNE, Australia and BOSTON , July 29, 2026 /PRNewswire/ -- Melbourne- and Boston-based medical device company Navi Medical Technologies has closed a $A6.8 million capital raise to commercialise ... 2026-07-29T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology The global launch brings image-based morphology intelligence into routine hematology workflows through AI × CBM technology. ... 2026-07-29T Biotechnology Health Care/Hospital Medical Equipment
Torrey Pines Medicine Secures Angel Round to Advance Next-Generation Ultra-Long-Acting Peptide Therapeutics Led by Lotus Lake Capital, the financing will accelerate the development of TPM004, a differentiated ultra-long-acting amylin/calcitonin receptor dual agonist, and advance the company's proprietary PepTetris™ ... 2026-07-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
IHH Healthcare Expands 'IHH Catalyst' to North Asia to Accelerate Clinical Adoption of Healthcare Innovation Building on the success of its inaugural programme in India, IHH Healthcare is launching IHH Catalyst \| North Asia Edition to help startups in Hong Kong, Chinese Mainland and neighbouring markets turn ... 2026-07-28T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

PR Newswire Asia's news > Health Care/Hospital